IFI30 and glioma: IFI30‐mediated EGFR/AKT/GSK3β/β‐catenin signaling not only promotes the epithelial–mesenchymal transition‐like phenotype by upregulating the expression of Slug, but also subsequently enhanced invasion and chemoresistance of glioma cells.